The partnership with Juniper Networks expands Corero’s (LSE: CNS) sales force from just six to hundreds of salespeople.
The partnership with Juniper Networks expands Corero’s (LSE: CNS) sales force from just six to hundreds of salespeople.
Are today’s financial industry players paying attention to the revolution that is ongoing across the social media landscape today, being played out right in front their eyes?
MiFID II came into force on 3 January 2018. Among other things, this EU directive establishes the SME Growth Market concept. The European Commission hopes that this new market classification
Scott, a Team Member/Director at London South East, with a simple message of thanks to round out 2017 and the
#HEMO are a London-listed, US-based biotech company developing two revolutionary blood cancer treatments. CDX antibodies are intended to remove the need
Reabold Resources Co-Chief Executives Stephen Williams and Sachin Oza have just successfully raised ‘approximately six million pounds’ to invest in
Josh Blacher, CFO at Therapix Biosciences, describes how his company are developing a therapeutic approach to obstructive sleep apnea, and
Lionel Segard is Chairman & CEO of Quantum Genomics, a French biotech company launched 11 years ago. Quantam are developing
Global oil giant Royal Dutch Shell has ended its Scrip Dividend Programme and returned to paying cash divis, but how do the fundamentals look? And it makes a major shift
Peter Garcia, the CFO at PDL BioPharma explains that in his view, PDL is ‘unique’. Located in Lake Tahoe, Nevada,
Erik Kinnman, CEO of Swedish biotech company NeuroVive Pharmaceutical, says that his company are at the forefront of research into